Interius BioTherapeutics
Philadelphia, United States· Est. 2018
Interius engineers targeted programmable lentiviral vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.
Private Company
Total funding raised: $90M
About
Interius engineers targeted programmable lentiviral vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.
RNA & Gene TherapyCell & Gene Therapy
Funding History
2Total raised:$90M
Series A$75MNov 15, 2023
Seed$15MMar 15, 2022